Categories: News

Elevating Healthcare Innovation: ICP DAS-BMP Brings Advanced TPU Portfolio at Medtec China 2025

HSINCHU, Sept. 9, 2025 /PRNewswire/ — ICP DAS-BMP (Biomedical Polymers), a Taiwan-based manufacturer and supplier of medical-grade TPU (thermoplastic polyurethane), is pleased to announce its participation in Medtec China 2025, to be held from September 24 to 26 at the Shanghai World Expo Exhibition & Convention Center.

- Advertisement -

The spotlight of this year’s exhibit will be the low-migration ARP-B20 TPU, developed to meet ISO 10993 biocompatibility standards and suitable for 90-day implant applications. Low-migration TPU significantly reduces additive migration during the heat-setting process, helping catheters maintain a clean, smooth surface throughout their shelf life. With 15 color options, this material offers broad design flexibility and enables customized solutions for specific clinical needs.

- Advertisement -

ICP DAS-BMP will also showcase a wide selection of TPU materials for diverse medical applications. The basic Arothane™, Alithane™, and Durathane™ TPUs (ARP/ALP/ALC series) meet the requirements for most body-contact medical devices, especially barium sulfate-containing grades such as B20 or B40. The Arothane™ ARP-B20 and Durathane™ ALC-B40 have passed the ISO 10993-6 13-week implantation test, making them suitable for implantation up to 90 days. Excellent dispersibility and biological safety make them a preferred choice for invasive catheters.

- Advertisement -

For thin-walled medical devices or guidewire coatings, the Arothane™ ARP-W and ARP-WG series, containing 40–60% Tungsten, offer excellent radiopacity. The soft ARP series, with hardness below 70A, delivers flexibility and mechanical strength for devices requiring both durability and patient comfort.

- Advertisement -

The Engineering Arothane™ TPU (EARP series) features a high glass transition temperature and outstanding light transmission, making it ideal for orthodontic components, Luer-Lock connectors, and other precision devices.

- Advertisement -

Together, these offerings form a comprehensive TPU portfolio meeting the evolving demands of modern healthcare technologies. Visit the ICP DAS-BMP team at Hall 2, Booth No. 2D402 to explore innovations and discover TPU solutions that enhance device performance, safety, and versatility.

- Advertisement -

About ICP DAS-BMP

- Advertisement -

ICP DAS-BMP, a leading TPU manufacturer and supplier based in Taiwan, is ISO 13485 certified and operates specialized laboratories focused on quality management. Leveraging over thirty years of industrial automation expertise from its parent company ICP DAS, ICP DAS-BMP employs smart factory practices to enhance product quality and expedite delivery times. The company is committed to responsive after-sales support and flexible solutions, even for small order quantities, ensuring customer satisfaction and fostering long-term partnerships.

- Advertisement -

For more information, please visit: https://bmp.icpdas.com

- Advertisement -

Photo – https://mma.prnewswire.com/media/2760737/Image_ICP_DAS_BMP.jpg 
Logo – https://mma.prnewswire.com/media/2492260/icpdas_bmp_Logo.jpg

- Advertisement -

 

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/elevating-healthcare-innovation-icp-das-bmp-brings-advanced-tpu-portfolio-at-medtec-china-2025-302546633.html

- Advertisement -

Recent Posts

Chandigarh University researchers use Artificial Intelligence to develop Model for predicting Accurate Crop Yield; Innovation to benefit Indian Farmers

Researchers have leveraged Climate Data and Satellite Technology for developing the predictive modelCHANDIGARH, India, June…

51 minutes ago

Clean Energy Chain Section at the 4th CISCE Highlights Low-Carbon Innovation Across the Energy Value Chain

BEIJING, June 26, 2026 /PRNewswire/ -- The Clean Energy Chain section of the fourth China…

51 minutes ago

Advanced Manufacturing Chain Section at CISCE Highlights Low-Altitude Economy, Aviation Value Chain and New Materials Innovations

BEIJING, June 26, 2026 /PRNewswire/ -- With the theme of "Making Production More Efficient," the…

51 minutes ago

EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss

GENEVA, June 27, 2026 /PRNewswire/ -- Adults with both epilepsy and hearing loss who use…

52 minutes ago

Appili Therapeutics Reports Fiscal Year 2026 Financial and Operational Results

LIKMEZ® (ATI-1501) commercial momentum building in U.S. marketUS$40 million NIAID award supporting VXV-01 advancement through…

7 hours ago

Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards and Acceptance of Plan to Regain Compliance

BEDMINSTER, N.J., June 26, 2026 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (the “Company”) (NYSE…

7 hours ago